Texas iGEM 2026 · Synthetic Biology

Engineering Probiotics to Combat Malnutrition

Leveraging synthetic biology by engineering beneficial gut bacteria to enhance nutritional health and support healthy growth.

An engineered E. coli Nissle 1917 that secretes FAAH through an OmpA module to modulate gut bioactive-lipid mediators. It is a proof-of-concept, not a clinical claim.

  1. Illustration of a child's small and large intestine, seen through the body.

    Where

    It starts in the gut

    Appetite is not only decided in the brain. The gut reports on what has been eaten, and those reports shape whether a child feels like eating at all.

  2. Close view of the intestinal wall, its surface covered in finger-like villi, with small glowing molecules drifting between them.

    The lining

    Where the reading happens

    The intestinal wall is covered in villi. Cells here sense fats arriving from a meal and turn them into chemical messages.

  3. The same intestinal lining with a molecule labelled OEA, oleoylethanolamide, arriving at a labelled PPAR-alpha receptor.

    The signal

    A lipid meets its receptor

    One of those messages is oleoylethanolamide, or OEA, a bioactive lipid that binds the PPAR‑α receptor. This is the lever our project works on.

  4. A child's silhouette with the vagus nerve lit, running from the gut up to the brain.

    The route

    Gut to brain

    The signal travels the vagus nerve, the line that carries news from the gut to the brain. It is how a message made in the intestine becomes a feeling about food.

  5. Two bacteria side by side, labelled E. coli Nissle and F. prausnitzii.

    Two organisms

    A chassis and a source

    E. coli Nissle 1917 is a safe, well characterised probiotic that colonises the gut: our delivery vehicle. Faecalibacterium prausnitzii is a normal gut resident, and where our enzyme comes from.

  6. The same two bacteria, with a protein structure labelled FAAH enzyme appearing beside F. prausnitzii.

    The enzyme

    FAAH

    Fatty acid amide hydrolase acts on the bioactive lipids the gut uses for signalling, OEA among them. Changing how much of that signal is present is the whole point of the design.

  7. The FAAH enzyme transferring across to E. coli Nissle, where a small circular plasmid becomes visible inside the cell.

    The build

    Moving it into Nissle

    We build the enzyme into Nissle on a plasmid, with an OmpA secretion module so the enzyme is exported rather than kept inside the cell. Read the construct left to right just below.

  8. Engineered bacteria among the intestinal villi, releasing glowing molecules into the gut.

    The scope

    What we are and are not claiming

    The engineered bacterium sits in the gut and acts on the lipid signal there. This is a proof of concept about a mechanism, not a treatment and not a clinical claim.

    The full project description →

The eight illustrations above are stills from our promo video, generated with Runway AI. They are illustration, not data: the mechanism they show is described and cited on our Project Description page. Full disclosure of how we used AI is on our AI use page.

The construct

One plasmid, read left to right

A promoter drives expression, an OmpA signal exports the enzyme, FAAH does the work, and a terminator closes it out, assembled with In Vivo Assembly.

Who we are

Houston's first community high-school synthetic biology team

We recruit students from under-resourced schools and first-generation STEM backgrounds, working under faculty mentors from UT MD Anderson Cancer Center and the University of Houston. Access and equity aren't a side project for us. They're why we're here.

With thanks

Our supporters

Content pending

Sponsor logos and acknowledgements

The full sponsor wall lives on the Sponsors page.

  • Financial sponsors (tiered wall)
  • In-kind partners, for example synthesis, reagents, software
  • Each logo uploaded to iGEM servers with permission